References
- OmuroADeAngelisLMGlioblastoma and other malignant gliomas: a clinical reviewJAMA2013310171842185024193082
- JohnsonBEMazorTHongCMutational analysis reveals the origin and therapy-driven evolution of recurrent gliomaScience2014343618919324336570
- NiederCGrosuAMollsMA comparison of treatment results for recurrent malignant gliomasCancer Treat Rev200026639740911139371
- HuncharekMMuscatJTreatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patientsAnticancer Res1997182B13031311
- LiJQinSXuJApatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trialJ Clin Oncol201331263219322523918952
- LiJQinSXuJRandomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctionJ Clin Oncol201634131448145426884585
- ZhangLShiMHuangCA phase II, multicenter, placebo-controlled trial of apatinib in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after two previous treatment regimensJ Clin Oncol20123015_suppl7548
- HuXZhangJXuBMulticenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancerInt J Cancer201413581961196924604288
- HuXCaoJHuWMulticenter phase II study of apatinib in non-triple-negative metastatic breast cancerBMC Cancer20141411824383403
- QinSApatinib in Chinese patients with advanced hepatocellular carcinoma: a phase II randomized, open-label trialAsco Meeting Abstracts20143215_suppl4019
- DützmannSGeßlerFBinkARisk of ischemia in glioma surgery: comparison of first and repeat proceduresJ Neurooncol2012107359960722249690
- GalldiksNBerhornTBlauTDunklVFinkGRSchroeterM“One week on–one week off”: efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single centerJ Neurooncol2013112220921523299464
- ReardonDADesjardinsAVredenburghJJMetronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyBr J Cancer2009101121986199419920819
- FriedmanHSPradosMDWenPYBevacizumab alone and in combination with irinotecan in recurrent glioblastomaJ Clin Oncol200927284733474019720927
- YangQYGuoCCChenZPProfile of nimotuzumab in the treatment of high-grade gliomaOnco Targets Ther2015881982525926743
- EpelmanSOdoneVGorenderEMedeirosRSSMartinsLPhase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG)J Clin Oncol20153315_suppl10061
- LiJZhaoXChenLSafety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignanciesBMC Cancer201010152953620923544
- CoweyCLSonpavdeGHutsonTENew advancements and developments in treatment of renal cell carcinoma: focus on pazopanibOnco Targets Ther200934147155